Cancer.Net Specialty Editor: Brain Metastasis
Miami Cancer Institute, Miami, FL
Dr. Manmeet Ahluwalia is Deputy Director, Chief Scientific Officer and Chief of Solid Tumor Medical Oncology at Miami Cancer Institute of Baptist Health South Florida. He is a leading expert in brain metastases and primary brain tumors.
Dr. Ahluwalia received his medical degree from the Maulana Azad Medical College of the University of Delhi. He completed his residency at Fairview General Hospital and a fellowship training at the Roswell Park Cancer Institute.
Dr. Ahluwalia's research focuses on the development of new therapies for people with brain tumors and brain metastases. He is currently leading several clinical trials involving immune therapy and new targeted therapies as well as treatments targeting tumor blood vessels (angiogenesis) and cancer stem cells. His results have been presented nationally and internationally and have resulted in over 175 manuscripts. Dr. Ahluwalia serves as the Associate Editor on Tumor Section of Neurosurgery for the official Journal of Congress of Neurological Surgeons (CNS). He is the Associate Editor of The ASCO Post, and is the Section Editor of Neuro-Oncology for HemOnc Today. He serves as a reviewer on multiple journals including Cancer, Neuro-Oncology, Cancer Research, Journal of NeuroOncology, Expert Reviews in Neurotherapeutics, BMC Cancer, Molecular Cancer Research, Expert Review of Anticancer Therapy, Expert Opinion in Pharmacotherapy, and Journal of Neurology & Neurophysiology.
Dr. Ahluwalia has been a recipient of several prestigious awards, such as the National Cancer Institute/ CTEP Career Development Award for Clinical Trial in American Brain Tumor Consortium (ABTC), American Society of Clinical Oncology (ASCO) Leadership Development Program award, and has been nominated for the Leading in Healthcare award at the Cleveland Clinic.
Last updated: May, 2021